OBJECTIVE: We sought to identify genes with differential expression in cerebral cavernous malformations (CCMs), arteriovenous malformations (AVMs), and control superficial temporal arteries (STAs) and to confirm differential expression of genes previously implicated in the pathobiology of these lesions. METHODS: Total ribonucleic acid was isolated from four CCM, four AVM, and three STA surgical specimens and used to quantify lesion-specific messenger ribonucleic acid expression levels on human gene arrays. Data were analyzed with the use of two separate methodologies: gene discovery and confirmation analysis. RESULTS: The gene discovery method identified 42 genes that were significantly up-regulated and 36 genes that were significantly down-regulated in CCMs as compared with AVMs and STAs (P = 0.006). Similarly, 48 genes were significantly up-regulated and 59 genes were significantly down-regulated in AVMs as compared with CCMs and STAs (P = 0.006). The confirmation analysis showed significant differential expression (P < 0.05) in 11 of 15 genes (angiogenesis factors, receptors, and structural proteins) that previously had been reported to be expressed differentially in CCMs and AVMs in immunohistochemical analysis. CONCLUSION: We identify numerous genes that are differentially expressed in CCMs and AVMs and correlate expression with the immunohistochemistry of genes implicated in cerebrovascular malformations. In future efforts, we will aim to confirm candidate genes specifically related to the pathobiology of cerebrovascular malformations and determine their biological systems and mechanistic relevance.
OBJECTIVE: We sought to identify genes with differential expression in cerebral cavernous malformations (CCMs), arteriovenous malformations (AVMs), and control superficial temporal arteries (STAs) and to confirm differential expression of genes previously implicated in the pathobiology of these lesions. METHODS: Total ribonucleic acid was isolated from four CCM, four AVM, and three STA surgical specimens and used to quantify lesion-specific messenger ribonucleic acid expression levels on human gene arrays. Data were analyzed with the use of two separate methodologies: gene discovery and confirmation analysis. RESULTS: The gene discovery method identified 42 genes that were significantly up-regulated and 36 genes that were significantly down-regulated in CCMs as compared with AVMs and STAs (P = 0.006). Similarly, 48 genes were significantly up-regulated and 59 genes were significantly down-regulated in AVMs as compared with CCMs and STAs (P = 0.006). The confirmation analysis showed significant differential expression (P < 0.05) in 11 of 15 genes (angiogenesis factors, receptors, and structural proteins) that previously had been reported to be expressed differentially in CCMs and AVMs in immunohistochemical analysis. CONCLUSION: We identify numerous genes that are differentially expressed in CCMs and AVMs and correlate expression with the immunohistochemistry of genes implicated in cerebrovascular malformations. In future efforts, we will aim to confirm candidate genes specifically related to the pathobiology of cerebrovascular malformations and determine their biological systems and mechanistic relevance.
Authors: C J Gallione; E A Scheessele; D Reinhardt; A J Duits; J N Berg; C J Westermann; D A Marchuk Journal: Hum Genet Date: 2000-07 Impact factor: 4.132
Authors: M W Geraci; M Moore; T Gesell; M E Yeager; L Alger; H Golpon; B Gao; J E Loyd; R M Tuder; N F Voelkel Journal: Circ Res Date: 2001-03-30 Impact factor: 17.367
Authors: J van Beijnum; H B van der Worp; H M Schippers; O van Nieuwenhuizen; L J Kappelle; G J E Rinkel; J W Berkelbach van der Sprenkel; C J M Klijn Journal: J Neurol Neurosurg Psychiatry Date: 2007-01-26 Impact factor: 10.154
Authors: Shantel M Weinsheimer; Huichun Xu; Achal S Achrol; Boryana Stamova; Charles E McCulloch; Ludmila Pawlikowska; Yingfang Tian; Nerissa U Ko; Michael T Lawton; Gary K Steinberg; Steven D Chang; Glen Jickling; Bradley P Ander; Helen Kim; Frank R Sharp; William L Young Journal: Transl Stroke Res Date: 2011-12-01 Impact factor: 6.829
Authors: Peng Gao; Yongmei Chen; Michael T Lawton; Nicholas M Barbaro; Guo-Yuan Yang; Hua Su; Feng Ling; William L Young Journal: Neurosurgery Date: 2010-10 Impact factor: 4.654
Authors: Yongmei Chen; Wei Zhu; Andrew W Bollen; Michael T Lawton; Nicholas M Barbaro; Christopher F Dowd; Tomoki Hashimoto; Guo-Yuan Yang; William L Young Journal: Neurosurgery Date: 2008-06 Impact factor: 4.654
Authors: Changbin Shi; Robert Shenkar; Hongyan Du; Edward Duckworth; Harish Raja; H Hunt Batjer; Issam A Awad Journal: Stroke Date: 2009-03-12 Impact factor: 7.914
Authors: Yongmei Chen; Qi Hao; Helen Kim; Hua Su; Michelle Letarte; S Ananth Karumanchi; Michael T Lawton; Nicholas M Barbaro; Guo-Yuan Yang; William L Young Journal: Ann Neurol Date: 2009-07 Impact factor: 10.422